Remission in post-traumatic stress disorder (PTSD): Effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale

International Clinical Psychopharmacology

Volumn 19, Issue 2, 2004, Pages 85-87

  Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CAPS; CGI; DTS; PTSD; Remission; Sertraline

Indexed keywords

PLACEBO; SERTRALINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; REMISSION;

ADULT; ANTIDEPRESSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 1542358899     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200403000-00005     Document Type: Article

References (13)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd rev. edn. Washington, DC: American Psychiatric Association.
2. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM (1995). The development of a clinician-administered PTSD scale. J Traumat Stress 8:75-90.
3. Brady KT, Pearlstein T, Asnis GM, Baker DG, Rothbaum BO, Sikes CR, Farfel GM (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 283:1837-1844.
4. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JRT (1999). Fluoxetine in post-traumatic stress disorder. Br J Psychiatry 174:17-22.
5. Davidson JRT (1996). Davidson Trauma Scale (DTS). North Tonawanda, New York: Multi-Health Systems Inc., pp. 1-32.
6. Davidson JRT, Malik ML, Travers J (1997). The Structured Interview for PTSD (SIP): psychometric properties for DSM-IV criteria. Depress Anxiety 5:127-129.
7. Davidson JRT, Pearlstein T, Londborg PD, Brady KT, Rothbaum BO, Bell J, et al. (2001a). Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974-1981.
8. Davidson JRT, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001b). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58:485-492.
9. Davidson JRT, Tharwani HM, Connor KM (2002). Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. Depress Anxiety 15:75-78.
10. Guy W (1977). ECDEU Assessment Manual for Psychopharmacology, DHEW publication 76-338). Washington DC: Department of Health, Education and Welfare; pp. 217-222.
11. Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, et al. (2001). Sertraline treatment in of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Clin Psychiatry 62:325-331.
12. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62:860-868.
13. Weathers FW, Keane TM, Davidson JRT (2001). The Clinician Administered PTSD Scale: a review of first 10 years' research. Depress Anxiety 13:132-156.